---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-100078"
form_type: "8-K"
ticker: "EWTX"
cik: "0001710072"
company_name: "Edgewise Therapeutics, Inc."
filed_at: "2022-09-14T23:59:59+00:00"
generated_at: "2026-06-23T09:44:49.566099+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Edgewise Therapeutics announces public offering of 11.6M shares at $10.32/share, expected gross proceeds $120M

## Summary
- Underwritten 11,627,907 shares; underwriters have 30-day option for additional 1,744,186 shares.
- Public offering price $10.32/share; underwriters purchase at $9.70/share.
- Expected gross proceeds of $120M before offering expenses; closing expected September 16, 2022.
- Offering made via effective S-3 registration statement (333-264083); J.P. Morgan and SVB Securities as representatives.
- Underwriting agreement includes customary representations, warranties, and indemnification.

## SEC filing metadata
- accession: 0001104659-22-100078
- form_type: 8-K
- ticker: EWTX
- cik: 0001710072
- company_name: Edgewise Therapeutics, Inc.
- filed_at: 2022-09-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1710072/000110465922100078/0001104659-22-100078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1710072/000110465922100078/tm2221772d4_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-100078
- JSON: https://secwatch.observer/filing/0001104659-22-100078.json
- Plain text: https://secwatch.observer/filing/0001104659-22-100078.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.